The largest database of trusted experimental protocols

29 protocols using mo 10

1

Stereotaxic Viral Injections in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized with isoflurane, head-fixed to a stereotaxic frame, and thermally supported with a feedback-controlled heating pad (DC Temperature Control System, FHC). Buprenorphine (0.3 mg/kg) and meloxicam (1 mg/kg) were injected subcutaneously for post-operative pain relief. After incising the scalp over the cranium, small craniotomy was opened using a dental drill over the RSC, dorsal CA1 of the hippocampus, or the AV nucleus of the thalamus. The stereotaxic coordinates of the RSCg target were (relative to bregma, in mm) anteroposterior −1.6 and 2.0, lateral 0.1, and ventral 0.3, 0.6 and 0.9, CA1 target were anteroposterior −2.0, lateral 1.5, and ventral 1.4, and those of the AV target were anteroposterior −0.5, lateral 1.2, and ventral 2.8. A beveled injection pipette, back-filled with mineral oil and front-filled with AAV solution, was slowly advanced to the target depth, where a small volume (50 nL) of virus was injected using a displacement-driven injector (MO-10 Narishige). The pipette was left in place for 5 mins before retraction. Once retracted, the incision was closed with a nylon or silk suture.
+ Open protocol
+ Expand
2

Pharmacogenetic Manipulation of dmPFC

Check if the same lab product or an alternative is used in the 5 most similar protocols
AAV8-CaMKlla-hM4D-mCherry (DREADD virus) and AAV2-CaMKlla-mCherry (control virus) were purchased from the University of North Carolina Vector Core. For virus injection, P21 mice were anesthetized with isoflurane (4% for induction, 1.5% for maintenance). Dexamethasone (2 mg/kg bodyweight) was injected intramuscularly, and carprofen (5 mg/kg bodyweight) was injected intraperitoneally (i.p.). 200 nl virus was injected into dmPFC (AP +1.7 mm, ML 0.6 mm, depth −1.32 mm) at 40 nl/min using a custom-built injection system based on a single-axis oil hydraulic micromanipulator (MO-10, Narishige). The mouse received the analgesic buprenorphine (0.1 mg/kg, subcutaneous) postoperatively for 3 days. 2–3 weeks of incubation was allowed before the commencement of behavioral experiments. For pharmacogenetic manipulation, clozapine-N-oxide (CNO; 0.3 mg/kg body weight) was dissolved in sterile saline and injected i.p. 15 min prior to behavioral experiments. For vehicle control, saline was injected at the same time point instead. Viral injection sites were verified by post mortem examination of the co-expressed mCherry in brain slices.
+ Open protocol
+ Expand
3

Viral Targeting and Manipulation of Gustatory Cortex

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were anesthetized with a cocktail containing ketamine (70 mg/kg, intraperitoneally (i.p.)), xylazine hydrochloride (3.5 mg/kg), and acepromazine maleate (0.7 mg/kg), and placed onto a stereotaxic apparatus. The skull was exposed, and craniotomies were made above GC. For the behavior experiments (GluA2-Ctail, PSD-PDZ1/2, Empty Vector) and imaging (RAM), viruses (800 nl per hemisphere) were bilaterally microinjected into GC through a glass micropipette connected to a micromanipulator (Narishige, MO-10), at a rate of approximately 200 nl/min. To cover the whole GC, three injection sites were chosen for each hemisphere: anterior-posterior (AP) with reference to bregma: 1.0 mm, medial-lateral (ML): ±4.7 mm, dorsal-ventral (DV) with reference to the brain surface: −3.5 mm, −3.6 mm, −3.7 mm. To allow adequate diffusion of virus particles, the pipet remained in place for additional 5 minutes after injection and was slowly withdrawn from the site. For DREADDS experiments, hM4D(Gi)-mCherry (400 nl) was unilaterally injected into GC. To label conditioning-active neurons for electrophysiological experiments, either RAM alone (400 nl), or a cocktail containing RAM and GluA2-Ctail (1:1, 400 nl) were bilaterally infused.
+ Open protocol
+ Expand
4

Sparse Labeling of Cortical Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
To achieve sparse labeling of a few dozens of cortical neurons, a mixture of AAV2/1-hSyn-Cre (final titer ∼5 × 107 GC/mL) and AAV2/1-CAG-Flex-EGFP (∼2 × 1012 GC/mL) was injected (Economo et al., 2016 (link)). The injection procedure was similar as before (Wang et al., 2021 (link)). Mice were kept anesthetized under 1–2% isoflurane during the whole injection procedure. The viral mixture was delivered through an oil hydraulic micromanipulator (Narishige, MO-10, ∼17 nL/min for 50 nL) into mPFC (injection site, AP: +1.85, ML: 0.4, DV: 1.7), ALM (AP: +2.5, ML: 1.5, DV: 0.7), and V1 (AP: −3.78, ML: 2.3, DV: 0.6). Each mouse was injected unilaterally in one selected cortical area (mPFC, ALM or V1) or in three cortical areas (mPFC, ALM and V1). Mice were maintained for 5 weeks to allow stable and strong expression of EGFP.
+ Open protocol
+ Expand
5

Targeted Viral Injections in Mouse Brain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viruses or tracers were loaded into capillary tubes (PCR micropipette, Drummond) pulled into micropipettes with a Sutter P-30 puller. For injections targeting the LEC, a 1 mm craniotomy was centered at AP 3.5 mm, ML 3.5 mm from bregma. Injection needle was angled at 10 degrees laterally and inserted 3800–4000 μm deep from the brain surface. For viral injections targeting the VTA/SNc, 1 mm craniotomy was centered at AP 3.15 mm, ML 0.8 mm from bregma. The micropipette was lowered 4000 μm deep from the brain surface and allowed to settle for several minutes. Viruses were injected at approximately 0.1 μL/min using a hydraulic manipulator (MO-10, Narishige). After injecting the desired volume, the micropipette was allowed to settle for five minutes. It was then removed at approximately 1 mm/min. Craniotomies were sealed with Kwik-Sil silicone adhesive (World Precision Instruments). Finally, the incision was sutured closed and treated with Vetbond tissue adhesive (3M) and Neosporin. Mice received subcutaneous injections of Flunixin and Baytril daily as needed. For the induction of Cre/ERT2, tamoxifen (75 mg/kg body weight) was injected intracutaneously in Wfs1-Cre mice one week after the injection for consecutive three days.
+ Open protocol
+ Expand
6

Extracellular Recording of Spinal Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
This method has been reported in our previous study [18 (link)]. Briefly, after exposing the lumbar enlargement (L3–L5 spinal segments) by laminectomy, rats were mounted in a stereotaxic head holder (SR-5R, Narishige, Japan) and stabilized with clamps attached to L2 and T12 vertebral processes. The dura was carefully removed, and the spinal cord was covered with warm mineral oil (37°C). Extracellular recordings of the activity of single WDR neurons in SDH with receptive fields (RFs) located on ST36 were obtained with a glass microelectrode (impedance: 10~15 MΩ; the tip of the microelectrode: 1-2 μm (A-M Systems Co.)) filled with 2% Pontamine Sky Blue in 0.5 mol/L sodium acetate. Recording electrodes were lowered into the spinal cord using an electronic micromanipulator (MO-10, Narishige, Japan) in 1 μm steps: 0.5–1.2 mm lateral to the midline in the right side of spinal cord and 0.3–1.3 mm from the dorsal surface [23 (link)]. Recordings were made only from single neurons whose amplitude could be easily discriminated. Electrophysiological activity was amplified (DAM50, WPI, USA), filtered (bandwidth: 300–5000), audiomonitored, and recorded with data acquisition systems (MP150, Biopack, CA, USA). The recording site and ST36 were all in the right side of the rats.
+ Open protocol
+ Expand
7

Precise Targeting of Orofacial Motor Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
To label a specific group of orofacial motor neurons, AAV2-retro-CAG-Cre (1000 nl) was injected into either the mystacial pad, genioglossus, or masseter muscles at postnatal day 17 using a volumetric injection system (based on a single-axis oil hydraulic micromanipulator MO-10, Narishige International USA, Inc, East Meadow, NY, USA) (Petreanu et al., 2009 (link)) equipped with a pulled and beveled glass pipette (Drummond, 5-000-2005). Before injection, mice were anesthetized by a cocktail of ketamine and xylazine (100 mg/kg and 10 mg/kg, i.p.). For the mystacial pad, the virus was injected subcutaneously into the areas around C2 and B2 vibrissae (500 nl each). For the genioglossus, the virus was injected directly into the muscle after exposing it by ventral neck dissection. Briefly, the genioglossus muscle was exposed by making a small incision in the mylohyoid muscle after the anterior digastric muscle was split open in the midline. For the masseter, the virus was injected into the area between the buccal and marginal nerves after making a small incision on a skin.
+ Open protocol
+ Expand
8

Mouse Urocortin II Injection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were injected over 5 min with 0.5 μl phosphate-buffered saline (PBS) with or without mouse urocortin II (Sigma-Aldrich, 240 pmol) through pre-implanted cannulas under isoflurane anesthesia. Cannulas (stainless steel, 4mm, 22 Gauge) were capped (C315IS-4/SPC internal 33GA, Plastics One) and implanted ≥ 7 days before testing 0.5 mm rostral to Bregma at the midline without penetrating the dura mater. Injections were performed using pulled (Model P-87, Sutter) glass micropipettes (Wiretrol II) and a micro-injector (MO-10, Narishige) in a stereotactic apparatus (Model 900, David Kopf Instruments). Injections were placed 2.5 mm below the dura mater. Injected animals recovered for 2–3 h before tests. After testing, animals were injected with 0.5 μl 2% fast green in PBS, euthanized and their brains fixed, sliced, and examined to confirm correct drug placement.
+ Open protocol
+ Expand
9

Intracerebral Transplantation of GABAergic Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intracerebral administration of cryopreserved GFP+ GABAergic progenitors was performed with beveled glass micropipettes (50–70μm diameter, Drummond Scientific, USA) coupled to a stereotaxic apparatus and controlled with the help of a microinjector (MO-10, Narishige, Tokyo, Japan), as previously described [12 (link),13 (link)]. Cells were pelleted by centrifugation (5 min, 300xg) and resuspended in DMEM/F12 at 0.1–0.5x106 cells/μl. MGE cell suspension were loaded into glass micropipettes prefilled with pure mineral oil and then with DMEM/F12.
Transplants were performed in neonatal mice (P3-P5) as previously described [12 (link)]. Mice were anesthetized by hypothermia until pedal reflex was abolished (approximately 1–2 minutes). Anesthesia was maintained by performing surgery on a cold aluminum plate. We used the following stereotaxic coordinates from Bregma (according to the Atlas of Developing Mouse Brains E17, 5, P0 and P6. Paxino, George / Halliday) for cortex (2.2mm A, 3.5 mm L, 1.2 mm D), and hippocampus (-1.2 mm A, 1.7 mm L, 2.0 mm D). After surgical procedure, grafted mice were returned to their cages and analyzed one month later.
+ Open protocol
+ Expand
10

Monosynaptic rabies virus tracing

Check if the same lab product or an alternative is used in the 5 most similar protocols
A three-step monosynaptic rabies virus tracing was performed as described previously10 (link). Briefly, postnatal day 17 C57B/L6 mice were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg). AAV2-retro-Cre was injected into two sites in the mystacial pad (between the B1-B2 and C1-C2 vibrissae, 500nl each) using a volumetric injection system (based on a single-axis oil hydraulic micromanipulator MO-10, Narishige)48 (link) equipped with a beveled glass micropipette (Drummond, 5-000-2005). Twenty days or longer after the first injection, the mice were anesthetized with isoflurane (1~2%), placed in the stereotaxic instrument (Model 963, David Kopf Instruments), and stereotaxically injected with 120 nl of a 1:1 mixture of AAV2/8-CAG-Flex-TVA-mCherry and AAV2/8-CAG-Flex-oG into the lateral part of VII where vibrissa motor neurons reside (vFMN, 5.8 mm posterior, 1.38 mm lateral to the bregma, and 5.2 mm below the brain surface) at the rate of 30nl/min using a beveled glass micropipette equipped with a microsyringe pump (UMP3, WPI) controlled by Micro4 controller (WPI). Fourteen days later, 250 nl of EnvA(M21)-RV-ΔG-GFP (diluted at 1:10 in PBS) was injected into the same injection site. Five days later, the mice were perfused for histological analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!